| Q92330354 | A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells |
| Q26851160 | A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care |
| Q90352375 | ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer |
| Q46185130 | Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. |
| Q26786476 | Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors |
| Q90481740 | An evolving paradigm of cancer stem cell hierarchies: therapeutic implications |
| Q90045611 | Annurca apple polyphenol extract selectively kills MDA-MB-231 cells through ROS generation, sustained JNK activation and cell growth and survival inhibition |
| Q58744474 | Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death |
| Q38406751 | Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions |
| Q93049389 | Application of Nanotechnology in Targeting of Cancer Stem Cells: A Review |
| Q33977045 | Blocking the formation of radiation-induced breast cancer stem cells |
| Q49181990 | Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts. |
| Q27024816 | Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment |
| Q38540375 | Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology |
| Q42371594 | Cell cycle specific radiosensitisation by the disulfiram and copper complex |
| Q28484299 | Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells |
| Q28085377 | Chemotherapy targeting cancer stem cells |
| Q35542866 | Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram |
| Q44845181 | Condurango-glycoside-A fraction of Gonolobus condurango induces DNA damage associated senescence and apoptosis via ROS-dependent p53 signalling pathway in HeLa cells |
| Q38947366 | Copper signaling axis as a target for prostate cancer therapeutics |
| Q38792695 | Crystal structure and chemotherapeutic efficacy of the novel compound, gallium tetrachloride betaine, against breast cancer using nanotechnology. |
| Q38736335 | Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells |
| Q39266662 | Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells |
| Q36820304 | Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations |
| Q96128478 | Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting |
| Q57163862 | Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition |
| Q64892039 | Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma. |
| Q35825566 | Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. |
| Q28546890 | Disulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agent |
| Q89595843 | Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper |
| Q36063610 | Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions |
| Q47096948 | Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways. |
| Q37472766 | Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners |
| Q36562209 | Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway |
| Q64073074 | Disulfiram inhibits epithelial-mesenchymal transition through TGFβ-ERK-Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis |
| Q90478009 | Disulfiram reduces metastatic osteosarcoma tumor burden in an immunocompetent Balb/c or-thotopic mouse model |
| Q90609993 | Disulfiram suppressed ethanol promoted RANKL-induced osteoclastogenesis in vitro and ethanol-induced osteoporosis in vivo via ALDH1A1-NFATc1 axis |
| Q28541751 | Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis |
| Q37214346 | Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells |
| Q92483795 | Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase |
| Q39263561 | Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide |
| Q35054730 | Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells |
| Q38930082 | Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer |
| Q92630095 | Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways |
| Q41575123 | Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition |
| Q41082509 | Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2. |
| Q36837031 | Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells |
| Q36734783 | EM23, A Natural Sesquiterpene Lactone from Elephantopus mollis, Induces Apoptosis in Human Myeloid Leukemia Cells through Thioredoxin- and Reactive Oxygen Species-Mediated Signaling Pathways |
| Q37696104 | Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models |
| Q47278890 | GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers. |
| Q34481639 | High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells |
| Q37420053 | High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors |
| Q44452857 | How could a drug used to treat alcoholism also be effective against glioblastoma? |
| Q57070043 | Hydroxycobalamin catalyzes the oxidation of diethyldithiocarbamate and increases its cytotoxicity independently of copper ions |
| Q52560420 | IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets. |
| Q36595072 | Identification and characterization of small molecule inhibitors of a plant homeodomain finger |
| Q92239454 | Immunocyte Profiling Using Single-Cell Mass Cytometry Reveals EpCAM+ CD4+ T Cells Abnormal in Colon Cancer |
| Q38819831 | In Vitro Selective Anti-Proliferative Effect of Zinc Oxide Nanoparticles Against Co-Cultured C2C12 Myoblastoma Cancer and 3T3-L1 Normal Cells |
| Q91726656 | Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram |
| Q90079560 | Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram |
| Q90382769 | Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line |
| Q42365079 | Leptin signaling and cancer chemoresistance: Perspectives |
| Q91905865 | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| Q34365729 | Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo. |
| Q37424042 | Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors |
| Q34675192 | Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1) |
| Q36591484 | Mechanisms of chemoresistance in cancer stem cells |
| Q36163766 | Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism |
| Q64061518 | Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells |
| Q39321461 | MicroRNA expression analysis of mammospheres cultured from human breast cancers |
| Q49385440 | Modeling of a Hybrid Langmuir Adsorption Isotherm for Describing Interactions Between Drug Molecules and Silica Surfaces. |
| Q48209273 | Nanocarrier based approaches for targeting breast cancer stem cells. |
| Q28066297 | Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells |
| Q35606242 | Ovarian cancer stem cell markers: prognostic and therapeutic implications |
| Q52373664 | Pharmacological targets of breast cancer stem cells: a review. |
| Q37719254 | Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells. |
| Q94564542 | Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease |
| Q54538158 | Protein phosphatases 2A as well as reactive oxygen species involved in tributyltin-induced apoptosis in mouse livers. |
| Q35966191 | Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer |
| Q47609532 | Recent Advances in Antabuse (Disulfiram): the importance of its metal-binding ability to its anticancer activity. |
| Q90223689 | Redox regulation of cell state and fate |
| Q43234285 | Reply: Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells |
| Q36461628 | Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation |
| Q101049273 | Roles of Ion fluxes, metabolism and redox balance in cancer therapy |
| Q35667050 | Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation |
| Q46768943 | Selective killing of hepatocellular carcinoma HepG2 cells by three-dimensional nanographene nanoparticles based on triptycene |
| Q36088183 | Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition |
| Q92451410 | Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy |
| Q33572252 | Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment. |
| Q58744510 | Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents |
| Q39171958 | Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways |
| Q37629056 | Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells |
| Q49860324 | Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors |
| Q37264685 | The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells. |
| Q26775232 | The fate of chemoresistance in triple negative breast cancer (TNBC) |
| Q38498021 | The therapeutic potential of vaginal drug delivery in the treatment of cervical cancer |
| Q39361267 | Vaginal drug delivery for the localised treatment of cervical cancer |
| Q36962758 | Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling |
| Q35787510 | Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. |
| Q53794454 | [Cancer stem cells as the therapeutic target of tomorrow]. |